Trial Profile
An effect of Dexmedetomidine as an anesthetic adjuvant in patients undergoing transsphenoidal resection of pituitary tumor.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 May 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Anaesthesia
- Focus Therapeutic Use
- 02 May 2016 New trial record